Silica, apoptosis, and autoimmunity

Journal of Immunotoxicology

Volumn 1, Issue 3-4, 2005, Pages 177-187

  Brown, Jared M ^a   Pfau, Jean C ^a   Pershouse, Mark A ^a   Holian, Andrij ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27944474248     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.1080/15476910490911922     Document Type: Review

References (99)

1. Albert, M. L., Pearce, S. F., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., and Bhardwaj, N. 1998. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T-lymphocytes. J. Exp. Med. 188(7):1359-1368.
2. Barton, A., Lamb, R., Symmons, D., Silman, A., Thomson, W., Worthington, J., and Donn, R. 2003. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 4(7):487-491.
3. Bertho, N., Blancheteau, V. M., Setterblad, N., Laupeze, B., Lord, J. M., Drenou, B., Amiot, L., Charron, D. J., Fauchet, R., and Mooney, N. 2002. MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-delta isoenzyme. Int. Immunol 14(8):935-942.
4. Boatright, K. M., and Salvesen, G. S. 2003. Mechanisms of caspase activation. Curr. Opin. Cell. Biol. 15(6):725-731.
5. Borges, V. M., Lopes, M. F., Falcao, H., Leite-Junior, J. H., Rocco, P. R., Davidson, W. F., Linden, R., Zin, W. A., and DosReis, G. A. 2002. Apoptosis underlies immunopathogenic mechanisms in acute silicosis. Amer. J. Respir. Cell. Mol. Biol. 27(1):78-84.
6. Bramwell, B. 1914. Diffuse scleroderma: Its frequency; its occurrence in stone masons; its treatment by fibrolysis. Edinburgh Med. J. 12:387.
7. Brodie, C., and Blumberg, P. M. 2003. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 8(1):19-27.
8. Brody, A. R., Roe, M. W., Evans, J. N., and Davis, G. S. 1982. Deposition and translocation of inhaled silica in rats. Quantification of particle distribution, macrophage participation, and function. Lab. Invest. 47(6):533-542.
9. Brown, J. M., Pfau, J. C., and Holian, A. 2004. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal. Toxicol. 16(3):133-139.
10. Calandra, T., and Roger, T. 2003. Macrophage migration inhibitory factor: A regulator of innate immunity. Nat. Rev. Immunol. 3(10):791-800.
11. Caplan, A. 1953. Certain unusual radiological appearances in the chest of coalminers suffering from rheumatoid arthritis. Thorax 8(1):29-37.
12. Casciola-Rosen, L., Wigley, F., and Rosen, A. 1997. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: Implications for pathogenesis. J. Exp. Med. 185(1):71-79.
13. Castranova, V. D., and Vallyathan, V. 1996. Role of Surface Free Radicals in the Pathogenicity of Silicosis: Silica and Silica-Induced Lung Diseases. CRC Press, Florida.
14. Chao, S. K., Hamilton, R. F., Pfau, J. C., and Holian, A. 2001. Cell surface regulation of silica-induced apoptosis by the SR-A scavenger receptor in a murine lung macrophage cell line (MH-S). Toxicol. Appl. Pharmacol. 174(1):10-16.
15. Cohen, P. L., and Eisenberg, R. A. 1991. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
16. Cooper, G. S., Miller, F. W., and Germolec, D. R. 2002. Occupational exposures and autoimmune diseases. Int. Immunopharmacol. 2(2-3):303-13.
17. Creagh, E. M., Conroy, H., and Martin, S. J. 2003. Caspase-activation pathways in apoptosis and immunity. Immunol. Rev. 193:10-21.
18. Davis, G. S., Holmes, C. E., Pfeiffer, L. M., and Hemenway, D. R. 2001. Lymphocytes, lymphokines, and silicosis. J. Environ. Pathol. Toxicol. Oncol. 20(Suppl 1):53-65.
19. Davis, G. S., Leslie, K. O., and Hemenway, D. R. 1998. Silicosis in mice: Effects of dose, time, and genetic strain. J. Environ. Pathol. Toxicol. Oncol. 17(2):81-97.
20. Davis, G. S., Pfeiffer, L. M., and Hemenway, D. R. 1998. Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. J. Environ. Pathol. Toxicol. Oncol. 17:99-114.
21. Davis, G. S., Pfeiffer, L. M., and Hemenway, D. R. 2000. Interferon-gamma production by specific lung lymphocyte phenotypes in silicosis in mice. Am. J. Respir. Cell. Mol. Biol. 22(4):491-501.
22. Donn, R., Alourfi, Z., Zeggini, E., Lamb, R., Jury, F., Lunt, M., Meazza, C., De Benedetti, F., Thomson, W., and Ray, D. 2004. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum. 50(5):1604-1610.
23. Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., and Henson, P. M. 1998. Macrophages that have ingested apoptotic cellsinvitroinhibit proinflammatory cytokine productionthrough autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101(4):890-898.
24. Foote, A., Briganti, E. M., Kipen, Y., Santos, L., Leech, M., and Morand, E. F. 2004. Macrophage migration inhibitory factor in systemic lupus erythematosus. J. Rheumatol. 31(2):268-273.
25. Friedetzky, A., Garn, H., Kirchner, A., and Gemsa, D. 1998. Histopathological changes in enlarged thoracic lymph nodes during the development of silicosis in rats. Immunobiology 199(1):119-132.
26. Garn, H., Friedetzky, A., Davis, G. S., Hemenway, D. R., and Gemsa, D. 1997. T-lymphocyte activation in the enlarged thoracic lymph nodes of rats with silicosis. Am. J. Respir. Cell. Mol. Biol. 16(3):309-316.
27. Garn, H., Friedetzky, A., Kirchner, A., Jager, R., and Gemsa, D. 2000. Experimental silicosis: A shift to a preferential IFN-gamma-based Th1 response in thoracic lymph nodes. Am. J. Physiol. Lung. Cell. Mol. Physiol. 278(6):L1221-1230.
28. Greidinger, E. L. 2001. Apoptosis in lupus pathogenesis. Front. Biosci. 6:D1392-1402.
29. Gumireddy, K., Reddy, C. D., and Swamy, N. 2003. Mitogen-activated protein kinase pathway mediates DBP-maf-induced apoptosis in RAW 264.7 macrophages. J. Cell. Biochem. 90(1):87-96.
30. Gutierrez-Pabello, J. A., McMurray, D. N., and Adams, L. G. 2002. Upregulation of thymosin beta-10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis. Infect. Immun. 70(4):2121-2127.
31. Hall, A. K. 1995. Thymosin beta-10 accelerates apoptosis. Cell. Mol. Biol. Res. 41(3):167-180.
32. Hamilton, R. F., Iyer, L. L., and Holian, A. 1996. Asbestos induces apoptosis in human alveolar macrophages. Am. J. Physiol. 271 (5 Pt 1): L813-819.
33. Hamilton, R. F., Jr., Pfau, J. C., Marshall, G. D., and Holian, A. 2001. Silica and PM1648 modify human alveolar macrophage antigen-presenting cell activity in vitro. J. Environ. Pathol. Toxicol. Oncol. 20(Suppl 1):75-84.
34. Hamzaoui, A., Ammar, J., Grairi, H., and Hamzaoui, K. 2003. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients. Mediators Inflamm. 12(4):209-214.
35. Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., and Nagata, S. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304(5674):1147-1150.
36. Hogan, S. L., Satterly, K. K., Dooley, M. A., Nachman, P. H., Jennette, J. C., and Falk, R. J. 2001. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J. Am. Soc. Nephrol. 12(1):134-142.
37. Holian, A., Uthman, M. O., Goltsova, T., Brown, S. D., and Hamilton, R. F. 1997. Asbestos and silica-induced changes in human alveolar macrophage phenotype. Environ. Health Perspect. 105(S5):1139-1142.
38. Hubbard, A. K. 1989. Role for T lymphocytes in silica-induced pulmonary inflammation. Lab. Invest. 61(1):46-52.
39. Hughes, J. M., Jones, R. N., Gilson, J. C., Hammad, Y. Y., Samimi, B., Hendrick, D. J., Turner-Warwick, M., Doll, N. J., and Weill, H. 1982. Determinants of progression in sandblasters' silicosis. Ann. Occup. Hyg. 26(1-4):701-712.
40. Hultman, P., Enestrom, S., Pollard, K. M., and Tan, E. M. 1989. Anti-fibrillarin autoantibodies in mercury-treated mice. Clin. Exp. Immunol. 78(3):470-477.
41. Iyer, R., Hamilton, R. F., Li, L., and Holian, A. 1996. Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages. Toxicol. Appl. Pharmacol. 141:84-92.
42. Kobzik, L. 1995. Lung macrophage uptake of unopsonized environmental particulates. Role of scavenger-type receptors. J. Immunol. 155(1):367-376.
43. Koeger, A. C., Lang, T., Alcaix, D., Milleron, B., Rozenberg, S., Chaibi, P., Arnaud, J., Mayaud, C., Camus, J. P., and Bourgeois, P. 1995. Silicaassociated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 74(5):221-237.
44. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407(6805):789-795.
45. Krieger, M. 1997. The other side of scavenger receptors: Pattern recognition for host defense. Curr Opin Lipidol 8(5):275-280.
46. Lan, H. Y., Yang, N., Nikolic-Paterson, D. J., Yu, X. Q., Mu, W., Isbel, N. M., Metz, C. N., Bucala, R., and Atkins, R. C. 2000. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int. 57(2):499-509.
47. Leech, M., Metz, C., Hall, P., Hutchinson, P., Gianis, K., Smith, M., Weedon, H., Holdsworth, S. R., Bucala, R., and Morand, E. F. 1999. Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum. 42(8):1601-1608.
48. Leigh, J., Wang, H., A., B., Peters, M., and Ruan, X. 1997. Silica-induced apoptosis in aleolar and granulomatous cells in vivo. Environ. Health. Perspect. 105(S5):1241-1245.
49. Lounsbury, K. M., Stern, M., Taatjes, D., Jaken, S., and Mossman, B. T. 2002. Increased localization and substrate activation of protein kinase Cdeltainlung epithelial cells following exposure to asbestos. Am. J. Pathol. 160(6):1991-2000.
50. Lue, H., Kleemann, R., Calandra, T., Roger, T., and Bernhagen, J. 2002. Macrophage migration inhibitory factor (MIF): Mechanisms of action and role in disease. Microbes Infect. 4(4):449-460.
51. Mayes, M. D. 1999. Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ. Health Perspect. 107(Suppl 5):743-748.
52. McHugh, N. J., Whyte, J., Harvey, G., and Haustein, U. F. 1994. Antitopoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity. Arthritis Rheum. 37(8):1198-1205.
53. Mevorach, D., Zhou, J. L., Song, X., and Elkon, K. B. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188(2):387-392.
54. Mohan, C., Morel, L., Yang, P., and Wakeland, E. K. 1998. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum. 41(9):1652-1662.
55. Morand, E. F., Leech, M., Weedon, H., Metz, C., Bucala, R., and Smith, M. D. 2002. Macrophage migration inhibitory factor in rheumatoid arthritis: Clinical correlations. Rheumatology (Oxford) 41(5):558-562.
56. Negorev, D., Riethman, H., Wechsler-Reya, R., Sakamuro, D., Prendergast, G. C., and Simon, D. 1996. The Bin1 gene localizes to human chromosome 2q14 by PCR analysis of somatic cell hybrids and fluorescence in situ hybridization. Genomics 33(2):329-331.
57. Nozawa, K., Casiano, C. A., Hamel, J. C., Molinaro, C., Fritzler, M. J., and Chan, E. K. 2002. Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Res 4(4):R3.
58. Ortiz, L. A., Lasky, J., Lungarella, G., Cavarra, E., Martorana, P., Banks, W. A., Peschon, J. J., Schmidts, H. L., Brody, A. R., and Friedman, M. 1999. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am. J. Respir. Cell. Mol. Biol. 20(4):825-833.
59. Otsuki, T., Sakaguchi, H., Tomokuni, A., Aikoh, T., Matsuki, T., Kawakami, Y., Kusaka, M., Ueki, H., Kita, S., and Ueki, A. 1998. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology 94:258-262.
60. Parks, C. G., Conrad, K., and Cooper, G. S. 1999. Occupational exposure to crystalline silica and autoimmune disease. Environ. Health Perspect. 107(S5):793-802.
61. Parks, C. G., Cooper, G. S., Nylander-French, L. A., Sanderson, W. T., Dement, J. M., Cohen, P. L., Dooley, M. A., Treadwell, E. L., StClair, E. W., Gilkeson, G. S., Hoppin, J. A., and Savitz, D. A. 2002. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, casecontrol study in the southeastern United States. Arthritis Rheum. 46(7):1840-1850.
62. Parks, C. G., Cooper, G. S., Nylander-French, L. A., Storm, J. F., and Archer, J. D. 2003. Assessing exposure to crystalline silica from farm work: A populationbased study in the Southeastern United States. Ann. Epidemiol. 13(5):385-392.
63. Pernis, B., and Paronetto, F. 1962. Adjuvant effects of silica (tridymite) on antibody production. Proc. Soc. Exp. Biol. Med. 110:390-392.
64. Pfau, J. C., Brown, J. M., and Holian, A. 2004. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 195(2-3):167-176.
65. Pfeffer, K. 2003. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 14(3-4):185-191.
66. Piguet, P. F., Collart, M. A., Grau, G. E., Sappino, A. P., and Vassalli, P. 1990. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344(6263):245-247.
67. Pollard, K. M., Lee, D. K., Casiano, C. A., Bluthner, M., Johnston, M. M., and Tan, E. M. 1997. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J. Immunol. 158(7):3521-3528.
68. Pongracz, J., Webb, P., Wang, K., Deacon, E., Lunn, O. J., and Lord, J. M. 1999. Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-delta. J. Biol. Chem. 274(52):37329-37334.
69. Potter, P. K., Cortes-Hernandez, J., Quartier, P., Botto, M., and Walport, M. J. 2003. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J. Immunol. 170(6):3223-3232.
70. Ricci-Vitiani, L., Conticello, C., Zeuner, A., and De Maria, R. 2000. CD95/CD95L interactions and their role in autoimmunity. Apoptosis 5(5):419-424.
71. Rieux-Laucat, F., LeDeist, F., and Fischer, A. 2003. Autoimmune lymphoproliferative syndromes: Genetic defects of apoptosis pathways. Cell Death Differ. 10(1):124-133.
72. Rodnan, G. P., Benedek, T. G., Medsger, T. A., Jr., and Cammarata, R. J. 1967. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann. Intern. Med. 66(2):323-334.
73. Ronchetti, A., Iezzi, G., Crosti, M. C., Garancini, M. P., Protti, M. P., and Bellone, M. 1999. Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells. J. Leukoc. Biol. 66(2):247-251.
74. Rosen, A., and Casciola-Rosen, L. 1999. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6(1):6-12.
75. Rustin, M. H., Bull, H. A., Ziegler, V., Mehlhorn, J., Haustein, U. F., Maddison, P. J., James, J., and Dowd, P. M. 1990. Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br. J. Dermatol. 123(6):725-734.
76. Santos, L., Hall, P., Metz, C., Bucala, R., and Morand, E. F. 2001. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: Interaction with glucocorticoids. Clin. Exp. Immunol. 123(2):309-314.
77. Savici, D., He, B., Geist, L. J., Monick, M. M., and Hunninghake, G. W. 1994. Silica increases tumor necrosis factor (TNF) production, in part, by upregulating the TNF promoter. Exp. Lung Res. 20(6):613-625.
78. Shevach, E. M. 2000. Regulatory T-cellsin autoimmmunity. Annu. Rev. Immunol 18:423-449.
79. Shukla, A., Stern, M., Lounsbury, K. M., Flanders, T., and Mossman, B. T. 2003. Asbestos-induced apoptosis is protein kinase C delta-dependent. Am. J. Respir. Cell. Mol. Biol. 29(2):198-205.
80. Siegel, R. M., Muppidi, J., Roberts, M., Porter, M., and Wu, Z. 2003. Death receptor signaling and autoimmunity. Immunol. Res. 27(2-3):499-512.
81. Silverstein, A. M. 2001. Autoimmunity versus horror autotoxicus: The struggle for recognition. Nat. Immunol. 2(4):279-281.
82. Simon, A. K., Gallimore, A., Jones, E., Sawitzki, B., Cerundolo, V., and Screaton, G. R. 2002. Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies. Cancer Cell 2(4):315-322.
83. Society, A. T. 1997. Adverse effects of crystalline silica exposure. Am. J. Respir. Crit. Care Med. 155:761-768.
84. Steenland, K., and Brown, D. 1995. Mortality study of gold miners exposed to silica and nonasbestiform amphibole minerals: An update with 14 more years of follow-up. Am. J. Ind. Med. 27(2):217-229.
85. Steenland, K., and Goldsmith, D. F. 1995. Silica exposure and autoimmune diseases. Am. J. Ind. Med. 28(5):603-608.
86. Subra, J. F., Renier, G., Reboul, P., Tollis, F., Boivinet, R., Schwartz, P., and Chevailler, A. 2001. Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin. Exp. Immunol. 126(3):540-544.
87. Tewari, M., Yu, M., Ross, B., Dean, C., Giordano, A., and Rubin, R. 1997. AAC-11, anovel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res. 57(18):4063-4069.
88. Thibodeau, M., Giardina, C., and Hubbard, A. K. 2003. Silica-induced caspase activation in mouse alveolar macrophages is dependent upon mitochondrial integrity and aspartic proteolysis. Toxicol. Sci. 76(1):91-101.
89. Thorburn, A. 2004. Death receptor-induced cell killing. Cell Signal. 16(2):139-144.
90. Tomokuni, A., Otsuki, T., Isozaki, Y., Kita, S., Ueki, H., Kusaka, M., Kishimoto, T., and Ueki, A. 1999. Serum levels of soluble Fas ligand in patients with silicosis. Clin. Exp. Immunol. 118:441-444.
91. Utz, P. J., and Anderson, P. 1998. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum. 41(7):1152-1160.
92. Vaishnaw, A. K., Toubi, E., Ohsako, S., Drappa, J., Buys, S., Estrada, J., Sitarz, A., Zemel, L., Chu, J. L., and Elkon, K. B. 1999. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95(Fas/APO-1) mutations. Arthritis Rheum. 42 (9):1833-1842.
93. Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J. H., Tschopp, J., and French, L. E. 1998. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282(5388):490-493.
94. Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., and Boldin, M. P. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:331-367.
95. Watanabe, S., Shirakami, A., Takeichi, T., Ohara, T., and Saito, S. 1987. Alterations in lymphocyte subsets and serum immunoglobulin levels in patients with silicosis. J. Clin. Lab. Immunol. 23(1):45-51.
96. Webb, P. R., Wang, K. Q., Scheel-Toellner, D., Pongracz, J., Salmon, M., and Lord, J. M. 2000. Regulation of neutrophil apoptosis: A role for protein kinase C and phosphatidylinositol-3-kinase. Apoptosis 5(5):451-458.
97. Whyte, J., Artlett, C., Harvey, G., Stephens, C. O., Welsh, K., Black, C., Maddison, P. J., and McHugh, N. J. 1994. HLA-DQB1 associations with anti-topoisomerase-1 antibodies in patients with systemic sclerosis and their first degree relatives. United Kingdom Systemic Sclerosis Study Group. J. Autoimmun 7(4):509-520.
98. Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., and Mountz, J. D. 1996. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98(5):1107-1113.
99. Zhou, X., Tan, F. K., Xiong, M., Milewicz, D. M., Feghali, C. A., Fritzler, M. J., Reveille, J. D., and Arnett, F. C. 2001. Systemic sclerosis (scleroderma): Specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J. Immunol. 167(12):7126-7133.